AFFiRiS and AC Immune, both Michael J. Fox Foundation grantees, announced a partnership that will advance a vaccine to lower levels of Parkinson’s protein alpha-synuclein.
— Read on www.michaeljfox.org/news/major-deal-pushes-parkinsons-vaccine-further-testing